KUSHAGRA NIJHARA: Open Payments
NPI 1831689348 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $104 |
| Alkermes, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Tris Pharma Inc | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: FANAPT, Auvelity, Dyanavel XR, INVEGA SUSTENNA, CAPLYTA, ARISTADA, LYBALVI.
Industry payments across CA — which companies pay providers there.
